TERT-BUTYL (4S)-3,3-DIFLUORO-4-HYDROXYPYRROLIDINE-1-CARBOXYLATE, 95%, 250mg

1-(3-Chloropropyl)pyrrolidine hydrochloride, 95.0%, 5g

Nonasaccharide Glc4Xyl3Gal2>75.0%(HPLC)100mg

5-Bromo-isoindoline hydrochloride, 97.0%, 5g

1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione, 95.0%, 5g

3-Methoxysalicylic acid, 95.0%, 25g

2-Hydroxy-5-(trifluoromethyl)benzaldehyde, 95.0%, 10g

trans-p-Coumaric Acid>98.0%(HPLC)(T)500g

2,5-Dimethoxyaniline>98.0%(GC)25g

Scintillation vials 20 ml Caps made from PP with PE foam seal, PET, 500 Piece(s)

Ethyl 2-(3-chloropyridin-2-yl)acetate, 98%, 5g

2-((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid, 95.0%, 1g

(3R,4R)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid, 95.0%, 250mg